MXPA03007332A - Composiciones de levotiroxina y metodos para elaborar la misma. - Google Patents
Composiciones de levotiroxina y metodos para elaborar la misma.Info
- Publication number
- MXPA03007332A MXPA03007332A MXPA03007332A MXPA03007332A MXPA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A MX PA03007332 A MXPA03007332 A MX PA03007332A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- compositions
- sodium
- making
- levothyroxine
- Prior art date
Links
- XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 229950008325 levothyroxine Drugs 0.000 title abstract 2
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 title abstract 2
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 abstract 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 2
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 229910052708 sodium Inorganic materials 0.000 abstract 2
- 239000011734 sodium Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000007909 solid dosage form Substances 0.000 abstract 1
- 239000005495 thyroid hormone Substances 0.000 abstract 1
- 229940036555 thyroid hormone Drugs 0.000 abstract 1
- 229940035722 triiodothyronine Drugs 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invencion se refiere generalmente a composiciones farmaceuticas estables y metodos para la elaboracion y administracion de tales composiciones. En un aspecto, la invencion caracteriza composiciones farmaceuticas estabilizadas que incluyen ingredientes farmaceuticamente activos tales como la levotiroxina sodio (T4) y liotironina sodio (T3) (farmacos de hormonas tiroides), preferiblemente en una forma de dosis solida de liberacion inmediata. Tambien se proporcionan metodos para la elaboracion y uso de tales composiciones estabilizadas y de liberacion inmediata.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26899801P | 2001-02-15 | 2001-02-15 | |
US26900901P | 2001-02-15 | 2001-02-15 | |
PCT/US2002/004665 WO2003070217A1 (en) | 2002-02-15 | 2002-02-15 | Levothyroxine compositions and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03007332A true MXPA03007332A (es) | 2005-11-10 |
Family
ID=28044645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03007332A MXPA03007332A (es) | 2001-02-15 | 2002-02-15 | Composiciones de levotiroxina y metodos para elaborar la misma. |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU2002240394A1 (es) |
BR (1) | BR0207299A (es) |
MX (1) | MXPA03007332A (es) |
NO (1) | NO20033636L (es) |
-
2002
- 2002-02-15 BR BR0207299-8A patent/BR0207299A/pt not_active IP Right Cessation
- 2002-02-15 MX MXPA03007332A patent/MXPA03007332A/es unknown
- 2002-02-15 AU AU2002240394A patent/AU2002240394A1/en not_active Abandoned
-
2003
- 2003-08-15 NO NO20033636A patent/NO20033636L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2002240394A1 (en) | 2003-09-09 |
BR0207299A (pt) | 2005-02-09 |
NO20033636D0 (no) | 2003-08-15 |
NO20033636L (no) | 2003-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
PT1412384E (pt) | Formulação estável de glp-1 modificado | |
BR0003158A (pt) | Formulação de dosagem oral de derretimentoinstantâneo | |
AP2001002264A0 (en) | Sustained release formulations for growth hormone secretagogues. | |
TW200505498A (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
AU7315301A (en) | Compounds and compositions for delivering active agents | |
PT893992E (pt) | Formas de dosagem oral de desintegracao rapida | |
TW200633730A (en) | Oral disintegrating dosage forms | |
GEP20053473B (en) | High Potency Dihydroergotamine Compositions | |
ATE486587T1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
IL165601A0 (en) | Oral pharmaceutical forms of liquid drugs having improved bioavailability | |
MX2009003030A (es) | Forma galenita para la administracion por via transmucosa de principios activos. | |
MXPA03007857A (es) | Compuestos y composiciones para entregar agentes activos. | |
AU2002231654A1 (en) | Pharmaceutical paste comprising an acid-labile active ingredient | |
WO2003028624A3 (en) | Levothyroxine compositions and methods | |
IL150528A0 (en) | Ibuprofen containing active agent preparation | |
AP2003002763A0 (en) | Controlled release formulations for oral administration | |
MX2010004556A (es) | Formulacion farmaceutica de acido clavulanico. | |
CY1107295T1 (el) | Σταθεροποιηση στερεων φορμουλων φαρμακων του θυρεοειδους | |
MXPA06000332A (es) | Nueva composicion farmaceutica solida que comprende amisulprida. | |
MY141012A (en) | Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser | |
WO2003013441A3 (en) | Levothyroxine compositions and methods | |
BR0209155A (pt) | Tablete farmacêutico tendo um teor de api elevado | |
WO2004014318A3 (en) | Levothyroxine compositions and methods | |
PL377683A1 (pl) | System terapeutyczny zawierający amoksycylinę i kwas klawulanowy |